Literature DB >> 16924224

Recent article by Shields et al titled "adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion".

Matthew Bennett, Ashley S Reynolds, Rob D Dickerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16924224     DOI： 10.1097/01.brs.0000229387.20297.b1

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN： 0362-2436            Impact factor:   3.468


× No keyword cloud information.
  2 in total

1.  Heterotopic ossification after the use of recombinant human bone morphogenetic protein-7.

Authors:  Marianthi Papanagiotou; Zoe H Dailiana; Theophilos Karachalios; Sokratis Varitimidis; Michael Hantes; Georgios Dimakopoulos; Marianna Vlychou; Konstantinos N Malizos
Journal:  World J Orthop       Date:  2017-01-18

2.  Combination of calcium sulfate and simvastatin-controlled release microspheres enhances bone repair in critical-sized rat calvarial bone defects.

Authors:  Yin-Chih Fu; Yan-Hsiung Wang; Chung-Hwan Chen; Chih-Kuang Wang; Gwo-Jaw Wang; Mei-Ling Ho
Journal:  Int J Nanomedicine       Date:  2015-12-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.